Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors
US7019111B2 · kind B2 · utility
3Cited by
56References
21Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2003 |
| Grant date | Mar 28, 2006 |
| Priority date | — |
| Expiry date | May 18, 2024 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention generally relates to compositions and methods for preventing and treating human diseases including, but not limited to, pathogens such as bacteria, yeast, parasites, fungus, viruses, and cancer. More specifically, embodiments described herein concern the manufacture and use of ligand/receptor specificity exchangers, which redirect existing antibodies in a subject to receptors present on pathogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.